Serpine1 Regulates Peripheral Neutrophil Recruitment and Acts as Potential Target in Ischemic Stroke
Send a publication request

Publication request

Thank you for your interest in our product range and your request for this publication, which will be sent to you if the research team and the journal allow it. Our commercial team will contact you as soon as possible.

- Categories : Ischemic Strokes , Publications

Z Pu, X Bao, S Xia et al

Nanjing University, Nanjing, Jiangsu, PeopleÕs Republic of China

Journal of Inflammation Research

Introduction: Peripheral neutrophil infiltration can exacerbate ischemiaÐreperfusion injury. We focused on the relationship between various peripheral immune cells and cerebral ischemiaÐreperfusion (I/R) injury.
Methods: In this study, we investigated the effects of dauricine on neuronal injury induced by ischemiaÐreperfusion and peripheral immune cells after ischemic stroke in mouse model, and we explored the undefined mechanisms of regulating peripheral immune cells through RNA sequencing and various biochemical verification in vitro and in vivo.
Results: We found that dauricine improved the neurological deficits of I/R injury, reduced the infarct volume, and improved the neurological scores. Furthermore, dauricine reduced the infiltration of neutrophils into the brain after MCAO-R and increased peripheral neutrophils but unchanged the permeability of the endotheliocyte Transwell system in an in vitro blood-brain barrier (BBB) model. RNA sequencing showed that chemotaxis factors, such as CXCL3, CXCL11, CCL20, CCL22, IL12a, IL23a, and serpine1, might play a crucial role. Overexpression of serpine1 reversed LPS-induced migration of neutrophils. Dauricine can directly bind with serpine1 in ligandÐreceptor docking performed with the Autodock and analyzed with PyMOL.
Conclusion: We identified chemotaxis factor serpine1 played a crucial role in peripheral neutrophil infiltration, which may contribute to reduce the neuronal injury induced by ischemiaÐreperfusion. These findings reveal that serpine1 may act as a potential treatment target in the acute stage of ischemic stroke.

BIOSEB Instruments Used:
Grip strength test (BIO-GS3)

Related products

Share this content